Background: We summarized the protocol-specified corticosteroid tapering regimens in clinical trials of moderate-severe ulcerative colitis (UC) and Crohn’s disease (CD) and calculated differences in rates of clinical remission vs corticosteroid-free clinical remission (CSF-CR).


Adrenal Cortex Hormones, Biological Products, Clinical Trials, Crohn's Disease, Drug Therapy, End Points, Maintenance Therapy, therapeutic use, Ulcerative Colitis

Read More